Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.64% | -8.00% | 51.17% | -346.08% | -2.79% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.81% | 42.33% | -24.30% | 25,022.22% | -97.95% |
| Change in Net Operating Assets | -784.42% | -105.91% | 154.84% | -239.81% | 5.20% |
| Cash from Operations | 1.74% | -28.23% | 85.70% | -824.39% | -282.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -13.89% | 3,700.00% | -- | -100.00% | 223.25% |
| Total Debt Repaid | -- | -- | 241.12% | -100.00% | -- |
| Issuance of Common Stock | -- | -- | -99.64% | 1,775.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -198.33% | 200.00% | -- |
| Cash from Financing | -14.68% | 62.51% | -89.19% | 849.15% | 281.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,693.33% | 104.82% | -156.55% | 1,864.29% | 250.00% |